Gugnoni Mila, Manicardi Veronica, Torricelli Federica, Sauta Elisabetta, Bellazzi Riccardo, Manzotti Gloria, Vitale Emanuele, de Biase Dario, Piana Simonetta, Ciarrocchi Alessia
Laboratory of Translational Research, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy.
Thyroid. 2021 Feb;31(2):247-263. doi: 10.1089/thy.2020.0001. Epub 2020 Jul 1.
Papillary thyroid cancers (PTCs) are common, usually indolent malignancies. Still, a small but significant percentage of patients have aggressive tumors and develop distant metastases leading to death. Currently, it is not possible to discriminate aggressive lesions due to lack of prognostic markers. Long noncoding RNAs (lncRNAs), which are selectively expressed in a context-dependent manner, are expected to represent a new landscape to search for molecular discriminants. Transforming growth factor β (TGFβ) is a multifunctional cytokine that fosters epithelial-to-mesenchymal transition and metastatic spreading. In PTCs, it triggers the expression of the metastatic marker Cadherin 6 (CDH6). Here, we investigated the TGFβ-dependent lncRNAs that may cooperate to potentiate PTC aggressiveness. We used a genome-wide approach to map enhancer (ENH)-associated lncRNAs under TGFβ control. Linc00941 was selected and validated using functional assays. A combined approach using bioinformatic analyses of the thyroid cancer (THCA)-the cancer genome atlas (TCGA) dataset and RNA-seq analysis was used to identify the processes in which linc00941 was involved in and the genes under its regulation. Correlation with clinical data was performed to evaluate the potential of this lncRNA and its targets as prognostic markers in THCA. Linc00941 was identified as transcribed starting from one of the TGFβ-induced ENHs. Linc00941 expression was significantly higher in aggressive cancer both in the TCGA dataset and in a separate validation cohort from our institution. Loss of function assays for linc00941 showed that it promotes response to stimuli and invasiveness while restraining proliferation in PTC cells, a typical phenotype of metastatic cells. From the integration of TCGA data and linc00941 knockdown RNA-seq profiling, we identified 77 genes under the regulation of this lncRNA. Among these, we found the prometastatic gene . Linc00941 knockdown partially recapitulates the effects observed upon CDH6 silencing, promoting cell cytoskeleton and membrane adhesions rearrangements and autophagy. The combined expression of CDH6 and linc00941 is a distinctive feature of highly aggressive PTC lesions. Our data provide new insights into the biology driving metastasis in PTCs and highlight how lncRNAs cooperate with coding transcripts to sustain these processes.
甲状腺乳头状癌(PTC)很常见,通常是惰性恶性肿瘤。然而,仍有一小部分但比例可观的患者患有侵袭性肿瘤并发生远处转移,最终导致死亡。目前,由于缺乏预后标志物,无法区分侵袭性病变。长链非编码RNA(lncRNA)以依赖于上下文的方式选择性表达,有望为寻找分子鉴别标志物提供新途径。转化生长因子β(TGFβ)是一种多功能细胞因子,可促进上皮-间质转化和转移扩散。在PTC中,它会触发转移标志物钙黏蛋白6(CDH6)的表达。在此,我们研究了可能协同增强PTC侵袭性的TGFβ依赖性lncRNA。我们采用全基因组方法来绘制受TGFβ调控的增强子(ENH)相关lncRNA图谱。选择了Linc00941并通过功能试验进行验证。使用对甲状腺癌(THCA)-癌症基因组图谱(TCGA)数据集的生物信息学分析和RNA测序分析的联合方法,来确定Linc00941参与的过程以及受其调控的基因。与临床数据进行相关性分析,以评估该lncRNA及其靶点作为THCA预后标志物的潜力。Linc00941被确定为从TGFβ诱导的ENH之一开始转录。在TCGA数据集中以及在我们机构的一个单独验证队列中,侵袭性癌症中Linc00941的表达均显著更高。对Linc00941的功能缺失试验表明,它在PTC细胞中促进对刺激的反应和侵袭性,同时抑制增殖,这是转移细胞的典型表型。通过整合TCGA数据和Linc00941敲低RNA测序分析,我们确定了受该lncRNA调控的77个基因。其中,我们发现了促转移基因。Linc00941敲低部分重现了CDH6沉默后观察到的效应,促进细胞骨架和膜黏附重排以及自噬。CDH6和Linc00941的联合表达是高度侵袭性PTC病变的一个显著特征。我们的数据为PTC转移的生物学机制提供了新见解,并突出了lncRNA如何与编码转录本协同维持这些过程。